Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - United States

United States

Revenue in the Skin Treatment market is projected to reach €3.08bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.78%, resulting in a market volume of €3.89bn by 2029.
In global comparison, most revenue will be generated in the United States (€3,077.00m in 2024).
In relation to total population figures, per person revenues of €9.00 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment (Pharmacies) market in United States is experiencing significant growth due to changing customer preferences, emerging trends in the market, and local special circumstances.

Customer preferences: Customers in the United States are increasingly concerned about their skin health and are seeking effective treatments to address various skin issues. The growing awareness about the importance of skincare and the desire for youthful and healthy-looking skin are driving the demand for skin treatment products in pharmacies. Customers are also looking for products that are safe, dermatologist-recommended, and affordable.

Trends in the market: One of the major trends in the skin treatment market in the United States is the increasing demand for natural and organic products. Customers are becoming more conscious about the ingredients used in skincare products and are opting for products that are free from harmful chemicals and artificial additives. This trend is driven by the growing preference for sustainable and eco-friendly options. Another trend in the market is the rise of personalized skincare. Customers are seeking customized solutions that cater to their specific skin concerns and needs. This trend is fueled by advancements in technology, such as artificial intelligence and machine learning, which enable companies to offer personalized recommendations based on individual skin types and conditions. Furthermore, there is a growing popularity of multi-functional skincare products that offer multiple benefits in a single product. Customers are looking for convenience and efficiency in their skincare routines, and multi-functional products that combine various treatments, such as moisturizing, anti-aging, and sun protection, are gaining traction in the market.

Local special circumstances: The United States has a large aging population, which is contributing to the growth of the skin treatment market. As people age, they are more likely to experience skin issues such as wrinkles, age spots, and dryness, leading to an increased demand for anti-aging and moisturizing products. Additionally, the United States has a diverse population with different skin types and concerns, creating a need for a wide range of skincare products to cater to various demographics.

Underlying macroeconomic factors: The strong economy in the United States is playing a significant role in the growth of the skin treatment market. With a higher disposable income, customers have more purchasing power to invest in skincare products. Furthermore, the increasing focus on self-care and wellness is driving the demand for skincare products as customers prioritize their personal health and appearance. In conclusion, the Skin Treatment (Pharmacies) market in United States is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for natural and organic products, personalized skincare solutions, and multi-functional products is driving the market forward. The aging population and diverse demographics in the United States also contribute to the growth of the market. With a strong economy and increasing focus on self-care, the future of the skin treatment market in the United States looks promising.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.